K.F. Gey

7.4k total citations · 1 hit paper
110 papers, 5.6k citations indexed

About

K.F. Gey is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, K.F. Gey has authored 110 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Biochemistry and 26 papers in Cellular and Molecular Neuroscience. Recurrent topics in K.F. Gey's work include Antioxidant Activity and Oxidative Stress (27 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuroscience and Neuropharmacology Research (17 papers). K.F. Gey is often cited by papers focused on Antioxidant Activity and Oxidative Stress (27 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuroscience and Neuropharmacology Research (17 papers). K.F. Gey collaborates with scholars based in Switzerland, United Kingdom and France. K.F. Gey's co-authors include A. Pletscher, Monika Eichholzer, W.P. Burkard, Pekka Puska, Eric Lüdin, David A. Wood, R A Elton, M. F. Oliver, Rudolph A. Riemersma and C. C. A. Macintyre and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

K.F. Gey

109 papers receiving 5.1k citations

Hit Papers

Risk of angina pectoris and plasma concentrations of vita... 1991 2026 2002 2014 1991 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.F. Gey Switzerland 39 2.2k 1.7k 1.5k 711 702 110 5.6k
Herbert J. Kayden United States 43 2.7k 1.2× 2.2k 1.3× 2.3k 1.5× 391 0.5× 910 1.3× 98 6.3k
Mario Comporti Italy 48 1.3k 0.6× 1.2k 0.7× 2.6k 1.7× 154 0.2× 804 1.1× 144 7.7k
D. P. R. Muller United Kingdom 35 1.0k 0.5× 1.1k 0.6× 1.1k 0.7× 253 0.4× 262 0.4× 106 3.4k
S. Renaud France 25 1.7k 0.8× 2.0k 1.2× 993 0.7× 78 0.1× 394 0.6× 77 7.0k
Kailash Prasad Canada 42 978 0.4× 1.3k 0.7× 1.4k 1.0× 144 0.2× 233 0.3× 229 7.2k
Andrew M. Jenner Singapore 42 1.2k 0.5× 776 0.5× 2.7k 1.9× 628 0.9× 496 0.7× 85 6.7k
Georg Waeg Austria 36 1.4k 0.6× 742 0.4× 1.9k 1.3× 376 0.5× 495 0.7× 67 5.3k
Garry J. Handelman United States 43 1.8k 0.8× 1.2k 0.7× 2.1k 1.4× 93 0.1× 490 0.7× 109 5.9k
Francisco Pérez‐Vizcaíno Spain 51 2.0k 0.9× 658 0.4× 3.0k 2.1× 287 0.4× 591 0.8× 213 8.7k
Silvana Hrelia Italy 47 863 0.4× 977 0.6× 2.9k 2.0× 307 0.4× 579 0.8× 194 7.0k

Countries citing papers authored by K.F. Gey

Since Specialization
Citations

This map shows the geographic impact of K.F. Gey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.F. Gey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.F. Gey more than expected).

Fields of papers citing papers by K.F. Gey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.F. Gey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.F. Gey. The network helps show where K.F. Gey may publish in the future.

Co-authorship network of co-authors of K.F. Gey

This figure shows the co-authorship network connecting the top 25 collaborators of K.F. Gey. A scholar is included among the top collaborators of K.F. Gey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.F. Gey. K.F. Gey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Doherty, Mark G., Sarah Gilchrist, Ian Young, et al.. (2010). Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial. European Journal of Nutrition. 49(8). 483–492. 13 indexed citations
2.
Tsubono, Yoshitaka, Shoichiro Tsugane, & K.F. Gey. (1999). Plasma Antioxidant Vitamins and Carotenoids in Five Japanese Populations With Varied Mortality From Gastric Cancer. Nutrition and Cancer. 34(1). 56–61. 29 indexed citations
3.
Woodside, Jayne V., Ian Young, J. W. G. Yarnell, et al.. (1999). Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial. Atherosclerosis. 144(2). 419–427. 16 indexed citations
4.
Woodside, Jayne V., Dorothy McMaster, Ian Young, et al.. (1998). Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. American Journal of Clinical Nutrition. 67(5). 858–866. 95 indexed citations
5.
Eichholzer, Monika, Hannes B. Stähelin, K.F. Gey, Eric Lüdin, & Florence Bernasconi. (1996). Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. International Journal of Cancer. 66(2). 145–150. 135 indexed citations
6.
8.
Gey, K.F.. (1993). Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. British Medical Bulletin. 49(3). 679–699. 203 indexed citations
9.
Longnecker, Matthew P., Paul Knekt, Abraham M. Y. Nomura, et al.. (1992). Serum α-Tocopherol Concentration in Relation to Subsequent Colorectal Cancer: Pooled Data From Five Cohorts. JNCI Journal of the National Cancer Institute. 84(6). 430–435. 79 indexed citations
10.
Clemens, Michael, et al.. (1992). Vitamine bei hochdosierter Chemo- und Strahlentherapie. Zeitschrift für Ernährungswissenschaft. 31(2). 110–120. 10 indexed citations
11.
Gey, K.F., et al.. (1991). β-Carotene and cancer prevention: the Basel Study. American Journal of Clinical Nutrition. 53(1). 265S–269S. 86 indexed citations
12.
Stähelin, Hannes B., K.F. Gey, Monika Eichholzer, et al.. (1991). Plasma Antioxidant Vitamins and Subsequent Cancer Mortality in the 12-Year Follow-up of the Prospective Basel Study. American Journal of Epidemiology. 133(8). 766–775. 171 indexed citations
13.
Clemens, Michael, Helmut Schmidt, Gerhard Ehninger, et al.. (1989). Decrease of Alpha‐Tocopherol and Beta‐Carotene by High‐Dose Radiochemotherapy Preceding Bone Marrow Transplantation. Annals of the New York Academy of Sciences. 570(1). 431–434. 5 indexed citations
14.
Burkard, W.P., K.F. Gey, H. Weiser, & Ulrich Schwieter. (1968). Decrease of norepinephrine in brain and heart of vitamin E deficient rats. Cellular and Molecular Life Sciences. 24(8). 807–808. 6 indexed citations
15.
Gey, K.F., W.P. Burkard, & A. Pletscher. (1965). Variation of the Norepinephrine Metabolism of the Rat Heart with Age. Gerontology. 11(1-2). 1–11. 53 indexed citations
16.
Gey, K.F. & A. Pletscher. (1964). EFFECTS OF CHLORPROMAZINE ON THE METABOLISM OF dl-2-C14-DOPA IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 145(3). 337–343. 10 indexed citations
17.
Gey, K.F. & F.S. Messiha. (1964). Einfluss der DOPA-Transaminierung auf die DOPA-Decarboxylierungin vitro. Cellular and Molecular Life Sciences. 20(9). 498–499. 9 indexed citations
18.
Gey, K.F., A. Pletscher, & W.P. Burkard. (1963). EFFECT OF INHIBITORS OF MONOAMINE OXIDASE ON VARIOUS ENZYMES AND ON THE STORAGE OF MONOAMINES. Annals of the New York Academy of Sciences. 107(3). 1147–1151. 23 indexed citations
19.
Burkard, W.P., K.F. Gey, & A. Pletscher. (1962). A new inhibitor of decarboxylase of aromatic amino acids. Cellular and Molecular Life Sciences. 18(9). 411–412. 55 indexed citations
20.
Gey, K.F. & A. Pletscher. (1961). INFLUENCE OF CHLORPROMAZINE AND CHLORPROTHIXENE ON THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE, NOREPINEPHRINE AND DOPAMINE. Journal of Pharmacology and Experimental Therapeutics. 133(1). 18–24. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026